Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
0(0%)
Results Posted
47%(8 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_4
11
48%
Ph phase_1
3
13%
Ph phase_2
4
17%
Ph phase_3
2
9%
Ph not_applicable
1
4%

Phase Distribution

3

Early Stage

4

Mid Stage

13

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
3(14.3%)
Phase 2Efficacy & side effects
4(19.0%)
Phase 3Large-scale testing
2(9.5%)
Phase 4Post-market surveillance
11(52.4%)
N/ANon-phased studies
1(4.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.4%

17 of 18 finished

Non-Completion Rate

5.6%

1 ended early

Currently Active

0

trials recruiting

Total Trials

23

all time

Status Distribution
Completed(17)
Terminated(1)
Other(5)

Detailed Status

Completed17
unknown5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
0
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (14.3%)
Phase 24 (19.0%)
Phase 32 (9.5%)
Phase 411 (52.4%)
N/A1 (4.8%)

Trials by Status

terminated14%
completed1774%
unknown522%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT03069703Phase 2

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy

Completed
NCT03165981Phase 4

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Completed
NCT03489018Phase 4

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants

Completed
NCT04275284

Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

Completed
NCT03384589Phase 2

CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study

Completed
NCT03530124Phase 4

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

Completed
NCT06210737Phase 4

A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years

Completed
NCT03803202Phase 1

A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine

Completed
NCT02637583Phase 4

Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels

Completed
NCT04384107Phase 3

Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)

Completed
NCT00566098Phase 1

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Completed
NCT05316831Phase 4

Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia

Completed
NCT04974294Phase 4

PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)

Unknown
NCT01953510Phase 2

Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam

Completed
NCT04525599Phase 1

A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

Completed
NCT03205371Phase 3

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers

Completed
NCT03260790Phase 4

Pneumococcal Vaccines in Patients With Asthma

Completed
NCT02012309Not Applicable

Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses

Unknown
NCT01282216Phase 2

Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide

Terminated
NCT03046134

Burden of Hospitalized Pneumonia in Korea COPD Population

Unknown

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
23